WI Harper Group | 2020-03-04

We continue to see many of WI Harper Group backed companies on the front lines of the battle against coronavirus since the outbreak. For example, the electrocardiograph of Edan Instruments, the ventilators other medical equipment from Resvent Medical and Aeonmed, and the ICU System of MedicalSystem Technology have been put into use in the designated hospitals for the treatment of pneumonia. RongCloud, Ikang, Histo Medical, LinkedSee, Merit Interactive, Infinite Intelligent Pharma, and other enterprises are supporting the battle by their remote consultation, medical cloud services, big data, and AI + drug R & D. In addition, Kindstar Global, LabTech, and others in the laboratory testing of viral nucleic acid are also in contribution and support.

| Kindstar Global was designated to conduct coronavirus nucleic acid tests

Kindstar Global headquarters — Wuhan Kindstar was designated by the government as the third-party medical testing laboratory in collaboration with Wuhan Huoshenshan Hospital. Meanwhile, Wuhan Kindstar was also appointed as the novel coronavirus nucleic acid testing entity by Hubei provincial Novel Coronavirus Pneumonia Prevention and Control Task Center.

According to the Wuhan Municipal Health Commission’s task deployment, the patient samples collected by relevant hospitals will be transported by professionals to Kindstar headquarters in Wuhan and tested there under the biosafety compliance. Test reports will be issued to assist in the diagnosis and treatment monitoring of patients in each hospital Kindstars headquarters is the largest single laboratory building in Asia with an area of 24000 square meters.

At the moment, approximately 12,000 square meters of laboratory space is available for diagnostic testing of the new coronavirus in the Kindstar laboratory building, of which 2,700 square meters has been reconstructed. The laboratory has been equipped with more than 40 large detection instruments, including 8 PCR machines. More than 300 employees have been called internally to fight the pneumonia. Kindstar is now able to perform more than 5,000 novel coronavirus tests per day, and the testing capacity will increase as the number of instruments deployed increases.